Audience
Clinical-grade decision support system that provides doctors histopathology diagnosis of cancer
About Qritive
Making cancer diagnosis fast, accurate, and affordable. During our lifetime, 1 in 3 of us will get cancer. But cancer diagnosis is slow and expensive because doctors are not equipped with modern automated tools. Qritive provides an AI-powered solution to help doctors analyse both microscopy images and text from patient data. As a result, hospitals will be more efficient in making cancer diagnoses, allowing them to save costs. Pantheon is a CE marked vendor-agnostic digital pathology platform that enables digitization of the entire pathology lab workflow and telepathology, supports rich report generation, and provides a platform for AI analysis of pathology whole-slide images. Differentiates a wide range of benign diseases and malignancies in breast tissue.
Other Popular Alternatives & Related Software
Aiforia
Aiforia equips pathologists and scientists in preclinical and clinical labs with powerful deep learning and cloud-based technology to advance their image analysis tasks and workflows. From empowering researchers in the identification of novel biomarkers of disease, and supporting R&D scientists in speeding up the time-to-market of novel drugs, to helping pathologists enhance the accuracy of cancer diagnostics, Aiforia has the expertise and experience to transform healthcare all the way from discovery to diagnosis. For clinical pathology labs aiming to increase productivity and improve diagnostic accuracy, the Aiforia Clinical Suites offer a portfolio of tools for AI-supported diagnostics, intelligent visualization, QC, and automated pre- and post-screening. We are currently developing Suites for some of the world’s most prevalent cancers and have CE-IVD marking for AI models in lung and breast cancer.
Learn more
Proscia
Concentriq, our AI-powered software platform sits at the intersection of digital and computational pathology, where functionality needed to carry out routine pathology operations connects with powerful AI applications to accelerate breakthroughs and improve patient outcomes. Laboratories worldwide recognize the challenges we all face today—a rising cancer burden, a shortage of pathologists, declining reimbursements, and the demands to rapidly modernize. However, with one billion pathology slides per year set to go digital, creating vast amounts of new data and information, the time to seize this moment is now. Digital pathology is giving today’s forward-thinking pathology organizations the means to overcome our collective challenges and fundamentally transform how we work and contribute to medicine and patient care.
Learn more
The Galen Platform
Ibex Medical Analytics is the pioneer in AI-powered cancer diagnostics in pathology. We are a multidisciplinary team of entrepreneurs, data scientists, software engineers and medical experts, working together to realize our vision is transforming cancer diagnostics with AI and improving patient care. Pathologists are challenged to provide accurate and timely analysis as the number of tests increases every year. Ibex uses artificial intelligence (AI) to develop clinical-grade solutions that help detect cancer as accurately as a human pathologist. Galen Platform uses algorithms to analyze images, detect and grade cancer in biopsies and point to other findings with high clinical importance, helping pathologists reduce diagnostic error rates and enable a more efficient workflow. Ibex’s Galen™ Prostate and Galen™ Breast are the first-ever AI-based cancer detection solutions used in routine clinical practice in pathology labs, with demonstrated success in detecting missed cancer cases.
Learn more
WRRisk
The product assigns a risk rating to a patient to drive a digital personalized screening plan for more consistent follow-up recommendations and more accurate diagnosis. This approach helps to catch cancers in the women that are at the greatest risk. WRRisk serves as a fully digital breast cancer risk assessment combining patient completed digital forms with a density assessment to provide a unified risk scorecard. WRRisk simplifies breast risk program maintenance by eliminating paper and automating many of the manual steps, from collecting forms to letter generation. The product equips patients and providers with the information they need. WRRisk Calculates 10-year and lifetime risk as well as risk-based on runner-up density.
Learn more
Integrations
No integrations listed.
Company Information
Qritive
Founded: 2017
Singapore
www.qritive.com
Videos and Screen Captures
Other Useful Business Software
Auth0 for AI Agents now in GA
Connect your AI agents to apps and data more securely, give users control over the actions AI agents can perform and the data they can access, and enable human confirmation for critical agent actions.
Product Details
Platforms Supported
Cloud
Training
Live Online
Support
Online
